FRAKIDEX, Collyre en solution bottle, 5 ml
Active ingredients: Dexamethasone sodium phosphate, Framycetin sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FRAKIDEX, Collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 5 ml
- Marketing authorisation holder
- LABORATOIRE CHAUVIN
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Nov 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60814943CIP73006744CIP133400930067444Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FRAMYCÉTINE (SULFATE DE)collyre | 630 000 Ul · 100 mL de collyre | SA |
| DEXAMÉTHASONE (PHOSPHATE SODIQUE DE)collyre | 0,10 g · 100 mL de collyre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.